Skip to main content
Log in

ENHANCE results to reduce ezetimibe/simvastatin prescribing

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. GfK Market Measures.Research reveals negative effects of ENHANCE trial results on anticipated Vytorin prescribing among physicians, with general/family practitioners reporting most negative response. Media Release: 15 Feb 2008. Available from: URL: http://www.gfkmarketmeasures.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

ENHANCE results to reduce ezetimibe/simvastatin prescribing. Pharmacoecon. Outcomes News 547, 6 (2008). https://doi.org/10.2165/00151234-200805470-00016

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805470-00016

Keywords

Navigation